Trimetrexate in advanced carcinoma of the esophagus

Uptake and efficacy of trimetrexate (TMQ, 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl] quinazoline), a non-classical antifolate in methotrexate-resistant leukemia cells in vitro

Barton A. Kamen, Beatrice Eibl, Arlene R. Cashmore et al. · Biochemical Pharmacology · 1984 · 112 citations

Medicine, Oncology, Pharmacology +7

Chemotherapy of advanced esophageal carcinoma: Eastern cooperative oncology group experience

Ediz Z. Ezdinli, Richard D. Gelber, Dinesh V. Desai et al. · Cancer · 1980 · 107 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Cytotoxic effects of folate antagonists against methotrexate-resistant human leukemic lymphoblast CCRF-CEM cell lines.

Enrico Mini, Barbara A. Moroson, Christine T. Franco et al. · PubMed · 1985 · 84 citations

Medicine, Biochemistry, Pharmacology +9

Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists.

T Ohnoshi, Takao Ohnuma, Isao Takahashi et al. · PubMed · 1982 · 64 citations

Medicine, Oncology, Pharmacology +16

Therapy of Advanced Esophageal Cancer with Bleomycin, Irradiation and Combination of Bleomycin with Irradiation

Krsto Kolarić, Z̆ Maričić, Ivo Dujmović et al. · Tumori Journal · 1976 · 53 citations

Medicine, Oncology, Radiation Oncology +9